In Corporate Livewire‘s June 2013 Round Table “Biotech & Pharmaceutical,” Dr. Gregory Bell and other leading experts discuss changes and analyze the effects they will have in the industry.
Assessing the economic case for Alzheimer’s disease policy prioritisation
The analysis has highlighted specific areas where more urgent action is needed, specifically: Accelerating diagnosing patients at scale; Supporting expansion...
